174 related articles for article (PubMed ID: 32511695)
21. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
[TBL] [Abstract][Full Text] [Related]
22. Alteration of Gut Microbiota in Carbapenem-Resistant Enterobacteriaceae Carriers during Fecal Microbiota Transplantation According to Decolonization Periods.
Lee JJ; Yong D; Suk KT; Kim DJ; Woo HJ; Lee SS; Kim BS
Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33578974
[TBL] [Abstract][Full Text] [Related]
23. Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
Bilinski J; Grzesiowski P; Sorensen N; Madry K; Muszynski J; Robak K; Wroblewska M; Dzieciatkowski T; Dulny G; Dwilewicz-Trojaczek J; Wiktor-Jedrzejczak W; Basak GW
Clin Infect Dis; 2017 Aug; 65(3):364-370. PubMed ID: 28369341
[TBL] [Abstract][Full Text] [Related]
24. Acquisition of Carbapenemase-Producing Enterobacteriaceae in Solid Organ Transplantation Recipients.
Lee KH; Han SH; Yong D; Paik HC; Lee JG; Kim MS; Joo DJ; Choi JS; Kim SI; Kim YS; Park MS; Kim SY; Yoon YN; Kang S; Jeong SJ; Choi JY; Song YG; Kim JM
Transplant Proc; 2018 Dec; 50(10):3748-3755. PubMed ID: 30577266
[TBL] [Abstract][Full Text] [Related]
25. Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients.
Mo Y; Hernandez-Koutoucheva A; Musicha P; Bertrand D; Lye D; Ng OT; Fenlon SN; Chen SL; Ling ML; Tang WY; Barkham T; Nagarajan N; Cooper BS; Marimuthu K
Emerg Infect Dis; 2020 Sep; 26(9):2182-2185. PubMed ID: 32818397
[TBL] [Abstract][Full Text] [Related]
26. Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.
Mookerjee S; Dyakova E; Davies F; Bamford K; Brannigan ET; Holmes A; Otter JA
J Hosp Infect; 2018 Sep; 100(1):15-20. PubMed ID: 29883616
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
28. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
[TBL] [Abstract][Full Text] [Related]
29. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.
Woodworth MH; Conrad RE; Haldopoulos M; Pouch SM; Babiker A; Mehta AK; Sitchenko KL; Wang CH; Strudwick A; Ingersoll JM; Philippe C; Lohsen S; Kocaman K; Lindner BG; Hatt JK; Jones RM; Miller C; Neish AS; Friedman-Moraco R; Karadkhele G; Liu KH; Jones DP; Mehta CC; Ziegler TR; Weiss DS; Larsen CP; Konstantinidis KT; Kraft CS
Sci Transl Med; 2023 Nov; 15(720):eabo2750. PubMed ID: 37910603
[TBL] [Abstract][Full Text] [Related]
30. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
[TBL] [Abstract][Full Text] [Related]
31. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
[TBL] [Abstract][Full Text] [Related]
32. Maintenance of Carbapenemase-Producing Enterobacteriaceae in a Farrow-to-Finish Swine Production System.
Mollenkopf DF; Mathys DA; Feicht SM; Stull JW; Bowman AS; Daniels JB; Wittum TE
Foodborne Pathog Dis; 2018 Jun; 15(6):372-376. PubMed ID: 29638168
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Fecal Microbiota Transplantation for Clearance of Multidrug-Resistant Organisms under Multiple Comorbidities: A Prospective Comparative Trial.
Shin J; Lee JH; Park SH; Cha B; Kwon KS; Kim H; Shin YW
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289668
[TBL] [Abstract][Full Text] [Related]
34. Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction.
Lowman W; Marais M; Ahmed K; Marcus L
J Hosp Infect; 2014 Oct; 88(2):66-71. PubMed ID: 25082751
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of fecal carriage of Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae among food handlers at the University of Gondar, Northwest Ethiopia.
Amare A; Eshetie S; Kasew D; Moges F
PLoS One; 2022; 17(3):e0264818. PubMed ID: 35298493
[TBL] [Abstract][Full Text] [Related]
36. Deposition of resistant bacteria and resistome through FMT in germ-free piglets.
Sun J; Chen YL; Ding YC; Zhong H; Wu M; Liu ZH; Ge LP
Lett Appl Microbiol; 2021 Aug; 73(2):187-196. PubMed ID: 33894059
[TBL] [Abstract][Full Text] [Related]
37. Fifty shades of graft: How to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria.
Davido B; Batista R; Dinh A; de Truchis P; Terveer EM; Roberts B; Kuijper EJ; Caballero S
Int J Antimicrob Agents; 2019 May; 53(5):553-556. PubMed ID: 30880228
[TBL] [Abstract][Full Text] [Related]
38. A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment.
Cheng VC; Chen JH; So SY; Wong SC; Chau PH; Wong LM; Ching RH; Ng MM; Lee WM; Hung IF; Ho PL; Yuen KY
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1418-1425. PubMed ID: 27619653
[TBL] [Abstract][Full Text] [Related]
39. Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-producing
Pérez-Nadales E; Cano Á; Recio M; Artacho MJ; Guzmán-Puche J; Doblas A; Vidal E; Natera C; Martínez-Martínez L; Torre-Cisneros J; Castón JJ
BMJ Open; 2022 Apr; 12(4):e058124. PubMed ID: 35387830
[TBL] [Abstract][Full Text] [Related]
40. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics.
Lee STM; Kahn SA; Delmont TO; Shaiber A; Esen ÖC; Hubert NA; Morrison HG; Antonopoulos DA; Rubin DT; Eren AM
Microbiome; 2017 May; 5(1):50. PubMed ID: 28473000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
